医学
分级(工程)
观察研究
围手术期
系统回顾
随机对照试验
梅德林
确定性
荟萃分析
医学物理学
重症监护医学
癫痫
外科
循证医学
不利影响
耐火材料(行星科学)
证据质量
癫痫外科
出版偏见
英语
临床试验
科克伦图书馆
作者
Carlos Quispe-Vicuña,Fernando Terry,Miguel Cabanillas‐Lazo,Alejandro Enríquez-Marulanda,Niels Pacheco-Barrios,Forough Yazdanian,Jean Pierre Zila-Velasque,David R. Soriano‐Moreno,Cristian Morán‐Mariños,Evan Luther,Lekhaj Chand Daggubati,Martín Andrés Merenzon,Jaime Lopez-Calle,Jorge G. Burneo,Ricardo J. Komotar,Ziev B. Moses,John David Rolston,Carlos Alva-Diaz
标识
DOI:10.3389/fsurg.2026.1642054
摘要
Introduction: Recently, MRI-guided laser interstitial thermal therapy (MRgLITT) has emerged as a therapeutic option for drug-resistant epilepsy (DRE). However, the absence of standardized clinical guidelines remains a significant issue. Objective: To conduct a systematic review of systematic reviews to provide a descriptive assessment of the quality of evidence regarding the application of MRgLITT for DRE. Methods: We conducted a comprehensive search in PubMed, Embase, Scopus, Web of Science, Cochrane Library, and Google Scholar up to May 30th, 2024. We evaluated the risk of bias in each study using the AMSTAR-2 tool. The primary outcomes assessed were seizure freedom and perioperative or postoperative complications rate, while the secondary outcome was reoperation rate. The certainty of the evidence was appraised using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach. Finally, pertinent findings were illustrated in a bubble plot. Results: A total of 16 systematic reviews met eligibility criteria, just including observational studies (cohorts and case series). Fourteen SRs scored "Critically low" with a median 8 [IQR: 5.25-8.25]. Seizure freedom rate ranged from 18.87% to 75.86%, and the most frequent cause of DRE was mesial temporal lobe epilepsy. The most common complications were visual field deficit (2.17%-7.5%) and intracranial hemorrhage (0.96%-8.6%). All the outcomes reported a "very low" certainty of evidence, as randomized studies were absent in the reviews. Conclusion: This overview provides comprehensive evidence on the application of MRgLITT for DRE). The evidence indicates a seizure freedom rate ranging from 18.87% to 75.86% with certainty levels raning from critically low to low. While these findings are promising, further primary and secondary studies are essential to establish definitive conclusions and assess the potential for future clinical applications or recommendations. Protocol Registration Number: CRD42022339024.
科研通智能强力驱动
Strongly Powered by AbleSci AI